Counselors in Chatham, VA Accepting Medicare

6 Counselors found. Showing 1 - 6

Jeneen L Robinson Counselor - Pastoral Medicare: Not Enrolled in Medicare Practice Location: 6871 Callands Rd, Chatham, VA 24531 Phone: 310-927-2685

Mrs. Deborah S Crowe, MS Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 25 Reid Street, Chatham, VA 24531 Phone: 434-432-8602    Fax: 434-432-8603

Ms. Cynthia Lynn Harford, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 2993 Banister Rd, Chatham, VA 24531 Phone: 276-403-2780

Kayla Mcguire Johnson Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 30 S Main St, Chatham, VA 24531 Phone: 434-432-4443

Mrs. Marie Rackley Paddock, LPC, NCC, EMDR Counselor Medicare: Not Enrolled in Medicare Practice Location: 1186 Fairview Rd N, Chatham, VA 24531 Phone: 434-770-4326    Fax: 434-432-4305

Suzanne Wood Sanford, LPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 25 Reid Street, Chatham, VA 24531 Phone: 434-432-8602    Fax: 434-432-8603

News Archive

ChanRx to evaluate AFIB drug, vanoxerine with closed Series A funding

ChanRx is developing a superior drug for treatment of atrial fibrillation (AFIB), and has closed its Series A funding with investments from Sante Ventures and company founder, Dr. Arthur "Buzz" Brown. The company, a spin out of Cleveland-based ChanTest, will use the funding to further evaluate the safety and efficacy of its proprietary AFIB drug, vanoxerine.

New quadruple fusion imaging helps diagnose eye conditions and tumors

A quadruple fusion optical and ultrasound imaging system has been developed that allows diagnosis of eye conditions or tumors or to see the environment inside the body using a transparent ultrasound transducer.

Update on the status of Somaxon Pharmaceuticals' NDA for Silenor provided

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today provided an update on the status of its New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.

Gates urges governments, wealthy donors not to cut aid to poor countries; Annual letter sets foundation's priorities

In a speech to the European Parliament on Tuesday, Bill Gates, co-chair of the Bill & Melinda Gates Foundation, "told European lawmakers in Brussels not to cut aid to poor countries despite the economic and budgetary problems facing" European Union (E.U.) countries, Agence France-Presse reports.

Read more Medical News

› Verified 5 days ago